Skip to main content

Table 3 Presenting symptoms of severe COVID-19 according to thrombosis and bleeding status of CLL patients with COVID-19

From: Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

 

Thrombosis

Bleeding

No (n = 409)

Yes (n = 51)

No (n = 445)

Yes (n = 23)

Fever

340/408 (83.3)

41/51 (80.4)

368/444 (82.9)

19/23 (82.6)

Dyspnea

241/406 (59.4)

33/51 (64.7)

264/441 (59.9)

15/23 (65.2)

Cough

223/408 (54.7)

25/51 (49.0)

239/444 (53.8)

11/23 (47.8)

Fatigue

86/408 (21.1)

9/51 (17.6)

94/444 (21.2)

4/23 (17.4)

Headache

24/408 (5.9)

4/51 (7.8)

23/444 (5.2)

3/23 (13.0)

GI symptoms

46/408 (11.3)

3/51 (5.9)

45/444 (10.1)

4/23 (17.4)

Anosmia/Ageusia

20/408 (4.9)

4/51 (7.8)

21/444 (4.7)

2/23 (8.7)

Myalgias/Arthralgias

38/408 (9.3)

5/51 (9.8)

41/444 (9.2)

2/23 (8.7)

  1. GI gastrointestinal
  2. *p < 0.05